By Michelle Liu and Mike Stobbe

A new variant of the coronavirus emerged Thursday in the United States, posing yet another public health challenge in a country already losing more than 3,000 people to COVID-19 every day.

The mutated version of the virus, first identified in South Africa, was found in two cases in South Carolina. Public health officials said it’s almost certain that there are more infections that have not been identified yet. They are also concerned that this version spreads more easily and that vaccines could be less effective against it.

The two cases were discovered in adults in different regions of the state and do not appear to be connected. Neither of the people infected has traveled recently, the South Carolina Department of Health and Environmental Control said Thursday.

“That’s frightening,” because it means there could be more undetected cases within the state, said Dr. Krutika Kuppalli, an infectious diseases physician at the Medical University of South Carolina in Charleston. “It's probably more widespread.”

The arrival of the variant shows that "the fight against this deadly virus is far from over,” Dr. Brannon Traxler, South Carolina's interim public health director, said in a statement. “While more COVID-19 vaccines are on the way, supplies are still limited. Every one of us must recommit to the fight by recognizing that we are all on the front lines now. We are all in this together.”

Viruses constantly mutate, and coronavirus variants are circulating around the globe, but scientists are primarily concerned with the emergence of three that researchers believe may spread more easily. Other variants first reported in the United Kingdom and Brazil were previously confirmed in the U.S.

As the variants bring a potential for greater infection risks in the U.S., pandemic-weary lawmakers in several states are pushing back against mask mandates, business closures and other protective restrictions ordered by governors.

States including Arizona, Michigan, Ohio, Maryland, Kentucky and Indiana are weighing proposals to limit their governors' abilities to impose emergency restrictions. Wisconsin’s Republican-controlled Assembly had been expected to vote to repeal Democratic Gov. Tony Evers’ mask mandate, but lawmakers abruptly called off the vote Thursday in the face of broad criticism and out of concern it would jeopardize more than $49 million in federal aid. Pennsylvania lawmakers are considering a constitutional amendment to strip the governor of many of his emergency powers.

Governors argue that they need authority to act swiftly in a crisis, and limitations could slow critical emergency responses.

Meanwhile, Nebraska health officials said the state could be days away from lifting restrictions on indoor gatherings, citing a low percentage of COVID-19 hospitalizations. Other states seeing declining infections are also loosening limitations on restaurants and other businesses, though experts have warned the public to stay vigilant about masks and social distancing or risk further surges.

In South Carolina, the state health agency said the variant was found in one person from the state's coastal region and another in its northeastern corner. The state gave little other information, citing privacy concerns, though Traxler said neither of the people was contagious any longer.

“Both were tested very early in the month, and my understanding is that both are doing well,” Traxler said.

South Carolina Gov. Henry McMaster, a Republican, loosened most of the state’s remaining pandemic restrictions in the fall. Spokesman Brian Symmes said McMaster does not plan to order new restrictions based on the discovery of the variant.

“This is important information for South Carolinians to have," McMaster said in a tweet, “but it isn’t a reason for panic.”

Scientists last week reported preliminary signs that some of the recent mutations may modestly curb the effectiveness of two vaccines, although they stressed that the shots still protect against the disease. There are also signs that some of the new mutations may undermine tests for the virus and reduce the effectiveness of certain treatments.

The coronavirus has already sickened millions and killed roughly 430,000 people in the United States.

While the rollout of vaccines has been slow, President Joe Biden has pledged to deliver 100 million injections in his first 100 days in office — and suggested it's possible the U.S. could reach 1.5 million shots a day.

While some European countries do extensive genetic testing to detect these variants, the U.S. has done little of this detective work. But scientists have been been quickly trying to do more, which has revealed the more contagious variants.

The Centers for Disease Control and Prevention has reported at least 315 cases of the U.K.-discovered variant in the United States. Those reports have come from at least 28 states, and health officials believe it could become the dominant strain in the U.S. by March. That variant has been reported in at least 70 countries.

The first U.S. case of the variant found in Brazil was announced earlier this week by health officials in Minnesota. It was a person who recently traveled to that South American nation. That version of the virus has popped up in more than a half-dozen countries.

The variant first found in South Africa was detected in October. Since then, it has been found in at least 30 other countries.

Some tests suggest the South African and Brazilian variants may be less susceptible to antibody drugs or antibody-rich blood from COVID-19 survivors, both of which help people fight off the virus.

Health officials also worry that if the virus changes enough, people might get COVID-19 a second time.

Biden on Monday reinstated COVID-19 travel restrictions on most non-U.S. travelers from Brazil, the U.K. and South Africa. The Centers for Disease Control and Prevention recommends that Americans avoid travel.

___

Stobbe reported from New York.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
Climate Experts Attend House Committee Meeting in Place of Big Oil Board Members
After months of investigation, board members from U.S. big oil companies were slated to appear before a House oversight committee this week to discuss their respective roles in pushing for climate initiatives internally. However, all four board members from Exxon, Shell, Chevron, and BP said they couldn't attend due to scheduling conflicts. Climate experts are testifying in their place about how effective big oil's climate promises have been so far. Meanwhile, President Joe Biden's lead science adviser Eric Lander has resigned after an investigation found he violated workplace policy. What will this mean for Biden's climate agenda? Amy Harder, executive editor of Cipher, a publication by Breakthrough Energy, joins Cheddar Climate to discuss.
Will The Texas Grid Fail Again? ERCOT Says They Are 'Ready For This Storm'
Although this week's weather is predicted to be less severe than the 2021 storm, Texans are preparing for the worst - stocking up on supplies and emptying shelves in grocery stores, once again. Some Texans still have not recovered from last year's tragedy, and are heading into the next few weeks with anxiety for what's to come. Leslie Beyer, CEO of the Houston-based energy workforce & technology council, joins Cheddar News to discuss if the Texas grid will fail again.
American Red Cross Calls for Donors Amid Worst Blood Shortage in Over a Decade
The American Red Cross has declared its first-ever "national blood crisis" in the United States. Since COVID hit the U.S. in March 2020, blood donations have declined by 10 percent. American Red Cross Medical Director, Dr. Baia Lasky joined Cheddar News to discuss the country facing the worst blood shortage in over a decade. Dr. Lasky noted that as much as 40 percent of Americans are eligible to donate blood but only about 4 percent do so. "This is going to be ongoing," she said. "This is not an acute shortage. We really do need the commitment of people to come out and donate and donate again." Appointments to donate can be made by using the Red Cross Donor App, at RedCrossBlood.org, or calling 1-800-RED CROSS (1-800-733-2767).
NFL Awards $1 Million to Study Impact of Cannabis and CBD on Pain Management
Eight months after the National Football League announced $1 million in research into cannabinoids, the NFL-NFLPA Joint Pain Management Committee has awarded the funding to two teams of medical researchers at the University of California San Diego and the University of Regina. The NFL says the studies will investigate the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players, respectively. Cheddar correspondent Chloe Ailello spoke with Jeff Miller, the executive vice president of communications, public affairs, and policy for the NFL, about the studies, as well as the recent lawsuit filed against the NFL by former Miami Dolphins head coach Brian Flores. "Maybe we can learn things from other alternative pain approaches that are going to benefit our player population and then sports medicine as a whole," Miller said.
How A.I. is Reinventing Remembrance; Biodiversity of the Humboldt Current
On this episode of Cheddar Innovates: CEO of HereAfter AI discusses how artificial intelligence can be used to preserve family history and stories, and allow you to 'talk' to loved ones that have passed; Creator of the board game 'Travel Explore Discover' explains how she came up with the idea for this informative and educational board game, and how she's using the proceeds to give back to her community; Cheddar gets a look at Curiosity Stream's 'The Humboldt Current.'
Long COVID: Millions Dealing with Residual Symptoms
Immunologist Dr. Purvi Parikh of the Allergy & Asthma Network joined Cheddar News to break down long Covid, in which Covid symptoms remain up to two years after infection; a phenomenon that has so far mystified health experts.
Factorial Energy Raises $200 Million to Accelerate Commercialization of Its Solid-State Batteries for Electric Vehicles
Solid-state battery maker Factorial Energy recently raised $200 million in a Series D round led by Mercedes-Benz and Stellantis. Factorial says the funding will be used to accelerate commercial production and deployment of its solid-state battery technology, which the company says is safer, and offers up to 50% more driving range than current lithium-ion technology. Factorial also has joint development agreements (announced in late 2021) with Mercedes-Benz, Stellantis, and Hyundai, three of the top 10 global automotive manufacturers, to commercialize its batteries. Factorial CEO Siyu Huang joined Cheddar News' Closing Bell to discuss.
Energy Storage Solutions Company Leclanché Powers EV Fleets to Reduce Emissisions
A 2021 report from UK Research and Innovation found that the shipping industry makes up at least 2.5 percent of the world's total CO2 emissions. It's a problem that energy solutions company, Leclanché, is trying to solve. Founded in 1909, the company has been developing and producing batteries for more than 100 years. Today, Leclanché's lithium-ion battery is used to electrify not just ships, but also railroad locomotives, trucks, and specialty vehicles. Cheddar News spoke with Pierre Blanc, chief technology and industrial officer of Leclanché, to discuss.
Load More